Glutamic acid decarboxylase - Gene to antigen to disease

Journal of Internal Medicine

Volumn 240, Issue 5, 1996, Pages 259-277

  Lernmark, A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; GLUTAMATE DECARBOXYLASE; GLUTAMIC ACID; ISOENZYME;

AUTOIMMUNITY; DIABETES MELLITUS; ENZYME MECHANISM; ENZYME REGULATION; GENETIC TRANSCRIPTION; HUMAN; IMMUNE RESPONSE; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; STIFF MAN SYNDROME; T LYMPHOCYTE;

EID: 0029683483     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1996.27859000.x     Document Type: Review

References (85)

1. Erlander MG, Tobin AJ. The structural and functional heterogeneity of glutamic acid decarboxylase: a review. Neurochem Res 1991; 16: 215-26.
2. Bu D-F, Erlander MG, Hitz BC, Tillakaratne NJK, Kaufman DL, Wanger-McPherson CB, Evans GA, Tobin AJ. Two human glutamate decarboxylases, 65-kDa GAD and 67-kDa GAD, are each encoded by a single gene. Proc Natl Acad Sci 1992; 89: 2115-19.
3. Karlsen AE, Hagopian WA, Grubin CE, Dube S, Disteche CD, Adler DA et al. Cloning and primary structure of a human islet isoform of glutamic acid decarboxylase from chromosome 10. Proc Natl Acad Sci USA 1991; 88: 8337-41.
4. Bu DF, Tobin AJ. The exon-intron organization of the genes (GAD1 and GAD2) encoding two human glutamate decarboxylases (GAD67 and GAD65) suggests that they derive from a common ancestral GAD. Genomics 1994; 21: 222-8.
5. Szabo G, Katarova Z, Greenspan R. Distinct protein forms are produced from alternatively spliced bicistronic glutamic acid decarboxylase mRNAs during development. Mol Cell Biol 1994; 14: 7535-15.
6. Nathan B, Bao J, Hsu C-C, Aguilar P, Wu R, Yarom M, Kuo C-Y, Wu J-Y. A membrane form of brain L-glutamate decarboxylase: identification, isolation, and its relation to insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 1994; 91: 242-6.
7. Persson Å, Pelto-Huikko M, Metsis M, Söder O, Brené S, Skog S, Hökfelt T, Ritzén M. Expression of the neurotransmitter-synthesizing enzyme glutamic acid decarboxylase in male germ cells. Molecular and Cellular Biology 1990; 10: 4701-11.
8. Adams TE, Alpert S, Hanahan D. Non tolerance and autoantibodies to a transgenic self antigen expressed in pancreatic B cells. Nature 1987; 325: 223-8.
9. 65 in human pancreatic islets. J Clin Endo. Metab 1992; 75: 1574-6.
10. Michalik M, Nelson J, Erecinska M. GABA production in rat islets of Langerhans. Diabetes 1993; 42: 1506-13.
11. Erlander MG, Tillakaratne NJK, Feldblum S, Patel N, Tobin AJ. Two genes encode distinct glutamate decarboxylase. Neuron 1991; 7: 91-100.
12. Katarova Z, Szabo G, Mugnaini E, Greenspan RJ. Molecular identification of the 62 kDa form of glutamic acid decarboxylase from the mouse. Eur J Neurosci 1990; 2: 190-202.
13. Lee DS, Tian J, Phan T, Kaufman DL. Cloning and sequence analysis of a murine cDNA encoding glutamate decarboxylase (GAD65). Biochim Biophys Acta 1993; 1216: 157-60.
14. Velloso LA, Eizirick DL, Karlsson FA, Kämpe O. Absence of autoantibodies against glutamate decarboxylase in the NOD mouse and low expression of GAD65 in mouse islets; differences between the animal model and human type 1 diabetes. Clin Exp Immunol 1994; 96: 129-37.
15. Kaufman DL, Clare-Salzer M, Tian J, Forsthuber T, Ting GSP. Robinson P et al. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 1993; 366: 69-72.
16. Tisch R, Yang X-D, Singer SM, Liblau RS, Fugger L, McDevitt HO. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 1993; 366: 72-5.
17. Kaufman DJ, Erlander MG, Clare-Salzler M, Atkinson MA, Maclaren NK, Tobin AJ. Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus. J Clin Invest 1992; 89: 283-92.
18. Reetz A, Solimena M, Matteoli M, Folli F, Takei K, De Camilli P. GABA and pancreatic J-cells: co-localization of glutamic acid decarboxylase (GAD) and GABA with synaptic-like microvesicles suggests their role in GABA storage and secretion. EMBO J 1991; 10: 1275-84.
19. De Camilli P. The Eighth Datta Lecture: Molecular Mechanisms in Synaptic Vesicle Recycling. FEBS Lett 1995; 369: 3-12.
20. Thomas-Reetz A, Hell JW, During MJ, Walch-Solimena C, Jahn R, De Camilli P. A K-aminobutyric acid transporter driven by a proton pump is present in synaptic-like microvesicles of pancreatic J-cells. Proc Natl Acad Sci USA 1993; 90: 5317-21.
21. Thomas-Reetz A, De Camilli P. A role for synaptic vesicles in non-neuronal cells: clues from pancreatic J-cells and from chromaffin cells. Faseb J 1994; 8: 209-16.
22. Solimena M, Aggujaro D, Muntzel C, Dirkx R, Butler M, De Camilli P, Mayday A. Association of GAD-65, but not of GAD-67, with the Golgi complex of transfected Chinese hamster ovary cells mediated by the N-terminal region. Proc Natl Acad Sci USA 1993; 90: 3073-7.
23. Dirkx R Jr, Thomas A, Linsong L, Lernmark Å, Sherwin RS, De Camilli P, Solimena M. Targeting of the 67-kDa isoform of glutamic acid decarboxylase to intracellular organelles is mediated by its interaction with the NH2-terminal region of the 65-kDa isoform of glutamic acid decarboxylase. J Biol Chem 1995; 270: 2241-6.
24. Shi Y, Veit B, Baekkeskov S. Amino acid residues 24-31 but not Palmitoylation of cysteines 30 and 45 are required for membrane anchoring of glutamic acid decarboxylase. GAD6. Cell Biol 1994; 124: 927-34.
25. Solimena M, De Camilli P. Diabetes: spotlight on a neuronal enzyme. Nature 1993; 366: 15-17.
26. Solimena M, Dirkx R, Butler M, Hermel JM, Guernaccia J, Marek K, David C, De Camilli P. Stiff-man syndrome and glutamic acid decarboxylase: an updated view. In: Tanaka C. ed. GABA 95. Basel: Birkhäuser Publishing Ltd. 1996.
27. Martin DL, Rimvall K. The regulation of GABA synthesis in the brain. J Neurochem 1993; 60: 395-407.
28. Martin DL, Martin SB, Wu S, Espina N. Regulatory properties of brain glutamate decarboxylase: the apoenzyme of GAD is present principally as one of two molecular forms of GAD in brain. J Neurosci 1991; 11: 2725-31.
29. Martin DL, Barke K. Are GAD65 and GAD67 associated with specific pools of GABA in brain? Perspectives in Developmental Biology 1996 (in press).
30. 67 protein is highly sensitive to small increases in intraneuronal gamma-aminobutyric acid levels. J Neurochem 1994; 62: 1375-81.
31. Sheikh S, Martin DL. Heteromers of glutamate decarboxylase isoforms occur in cerebellum. J Neurochem 1996 (in press).
32. Bottazzo GF, Dean BM, McNally JM, MacKay EH, Swift PGF, Gamble DR. In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med 1985; 313: 353-60.
33. Baekkeskov S, Nielsen JH, Marner B, Bilde T, Ludvigsson J, Lernmark Å. Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins. Nature 1982; 298: 167-9.
34. Christie MR, Hollands JA, Brown TJ, Michelsen BM, Delovitch TL. Detection of pancreatic islet 64,000 Mr autoantigens in insulin-dependent diabetes distinct from glutamate decarboxylase. J Clin Invest 1993; 92: 240-48.
35. Payton MA, Hawkes CJ, Christie MR. Relationship of the 37,000- and 40,000-Mr tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512). J Clin Invest 1995; 96: 1506-11.
36. Bingley PJ, Christie MR, Bonifacio E, Bonifanti R, Shattock M, Fonte MT, Bottazzo GF, Gale EA. Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes 1994; 43: 1304-10.
37. Christie MR, Genovese S, Cassidy D, Bosi E, Brown TJ, Lai M, Bonifacio E, Bottazzo GF. Antibodies to islet 37k antigen, but not to glutamate decarboxylase, discriminate rapid progression to IDDM in endocrine autoimmunity. Diabetes 1994; 43: 1254-9.
38. Genovese S, Bingley PJ, Bonifacio E, Christie MR, Shattock M, Bonfanti R, Foxon R, Gale EAM, Bottazzo GF. Combined analysis of IDDM-related autoantibodies in healthy school children. Lancet 1994; 344: 756.
39. Liblau RS, Singer SM, McDevitt HO. Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunology Today 1995; 16: 34-8.
40. Solimena M, Folli F, Denis-Donini S, Comi GC, Pozza G, De Camilli P, Vicari A. Autoantibodies directed against glutamic acid decarboxylase (GAD) in the cerebrospinal fluid and serum of a patient with stiff-man syndrome, epilepsy and type I diabetes mellitus. N Engl J Med 1988; 318: 1012-20.
41. Solimena M, Folli F, Aparisi R, Pozza G, De Camilli P. Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome. N Engl J Med 1990; 322: 1555-60.
42. Baekkeskov S, Aanstoot HJ, Christgau S, Reetz A, Solimena M, Cascalho M, Folli F, Richter-Olesen H, De Camilli P. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 1990; 347: 151-6.
43. Solimena M, De Camilli P. Autoimmunity to glutamic acid decarboxylase (GAD) in stiff-man syndrome and insulin-dependent diabetes mellitus. Trends Neurosci 1991; 14: 452-7.
44. Solimena M, Butler MH, De Camilli P. GAD, diabetes, and stiff-man syndrome: some progress and more questions. J Endocrinol Invest 1994; 17: 509-20.
45. Butler MH, Solimena M, Dirkx J R, Hayday A, De Camilli P. Identification of a dominant epitope of glutamic acid decarboxylase (GAD-65) recognized by autoantibodies in stiff-man syndrome. J Exp Med 1993; 178: 2097-106.
46. Kim J, Namchuck M, Bugawan T, Fu Q, Jaffe M, Shi Y et al. Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus. J Exp Med 1994; 180: 595-606.
47. Li L, Hagopian WA, Brashear HR, Daniels T, Lernmark Å. Identification of autoantibody epitopes of glutamic acid decarboxylase in stiff-man syndrome patients. J Immunol 1994; 152: 930-34.
48. Daw K, Powers AC. Two distinct glutamic acid decarboxylase auto-antibody specificities in IDDM target difference epitopes. Diabetes 1995; 44: 216-20.
49. Falorni A, Ackefors M, Carlberg C, Daniels T, Grubin CE, Li L, Persson B, Robertson J, Lernmark Å. Conservation of two major glutamic acid decarboxylase (GAD65) autoantibody epitopes among insulin-dependent diabetic children. Diabetologia 1995 (in press).
50. Björk E, Velloso LA, Kämpe O, Karlsson FA. GAD autoantibodies in IDDM. stiff-man syndrome, and autoimmune polyendocrine syndrome type I recognize different epitopes. Diabetes 1994; 43: 161-5.
51. Folli F, Sloimena M, Cofieli R, Folli F, Lichte B. Piccolo G et al. Autoantibodies to a 128-kDa synaptic protein in three women with the stiff-man syndrome and breast cancer. New Engl J Med 1993; 328: 546-51.
52. De Camilli PAT, Cofieli R, Folli F, Lichte B, Piccolo G. Meinck H-M et al. The synaptic vesicle-associated protein amphiphysin is the autoantigen of stiff-man syndrome with breast cancer. J Exp Med 1993; 178: 2219-23.
53. Falorni A, Kockum I, Sanjeevi CB, Lernmark Å. Pathogenesis of insulin-dependent diabetes mellitus. In: Kendall-Taylor P, ed. Clinical Endocrinology and Metabolism: Autoimmune Endocrine Disease. Vol. 9. Cambridge: Bailliére Tindall. 1995: 25-46.
54. Greenbaum CJ, Brooks-Worrell BM, Palmer JP. Lernmark Å. Autoimmunity and prediction of insulin dependent diabetes mellitus. Diabetes Annual 1994; 8: 21-52.
55. Hagopian WA, Michelsen B, Karlsen AE, Larsen F, Moody A. Grubin CE et al. Autoantibodies in IDDM primarily recognize the 65,000-Mr rather than the 67,000-Mr isoform of glutamic acid decarboxylase. Diabetes 1993; 42: 631-6.
56. Schmidli RS, Colman PG, Bonifacio E, Bottazzo GF, Harrison LC. High level of concordance between assays for glutamic acid decarboxylase antibodies. The First International Glutamic Acid Decarboxylase Antibody Workshop. Diabetes 1994; 43: 1005-9.
57. Schmidli RS, Colman PG, Bonifacio E. Disease sensitivity and specificity of 52 assays for glutamic acid decarboxylase antibodies. The Second International Glutamic Acid Decarboxylase Antibody Workshop. Diabetes 1995; 44: 636-40.
58. Grubin CE, Daniels T, Toivola B, Landin-Olsson M, Hagopian WA, Li L et al. A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia 1994; 37: 344-50.
59. Petersen JS, Hejnaes KR, Moody A, Karlsen AE, Marshall MO, Hoier-Madsen M, Boel E, Michelsen BK, Dyrberg T. Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay. Diabetes 1994; 43: 459-65.
60. Falorni A, Grubin CE, Takei I, Shimada A, Kasuga A, Maruyama T et al. Radioimmunoassay detects the frequent occurrence of autoantibodies to the Mr 65,000 isoform of glutamic acid decarboxylase in Japanese insulin-dependent diabetes. Autoimmunity 1994; 19: 113-25.
61. 3H recombinant human ligands. J Immunol Meth 1995; 186: 89-99.
62. Vandewalle CL, Falorni A, Svanholm S, Lernmark Å. Pipeleers DG, Gorus FK, Registry TBD. High diagnostic sensitivity of glutamate decarboxylase autoantibodies in IDDM with clinical onset between age 20 and 40 years. J Clin Endocrinol Metab 1995; 80: 846-50.
63. Schmidli RS, DeAizpurua HJ, Harrison LC, Colman PG. Antibodies to glutamic acid decarboxylase in at-risk and clinical insulin-dependent diabetic subjects: relationship to age, sex and islet cell antibody status, and temporal profile. J Autoimmunity 1994; 7: 55-66.
64. Tuomi T, Björses P, Falorni A, Partanen J, Perheentupa J, Lernmark Å, Miettinen A. Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with Apeced (autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy). J Clin Endo Metab 1996; 81: 1488-94.
65. Hallengren B, Falorni A, Landin-Olsson M, Lernmark Å, Papadopoulos KI, Sundkvist G. Islet cell and glutamic acid decarboxylase antibodies in hyperthyroid patients: at diagnosis and following treatment. J Intern Med 1996; 239: 63-8.
66. Yu L, Chase HP, Falorni A, Rewers M, Lernmark A, Eisenbarth GS. Sexual dimorphism in transmission to offspring of expression of islet autoantibodies. Diabetologia 1995; 38: 1353-7.
67. Tuomilehto J, Zimmet P, Mackay IR, Koskela P, Vidgren G, Tolvanen L et al. Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease. Lancet 1994; 343: 1383-5.
68. Landin-Olsson M, Nilsson KO, Lernmark Å, Sundkvist G. Islet cell antibodies and fasting C-peptide predict insulin requirement at diagnosis of diabetes mellitus. Diabetologia 1990; 33: 561-8.
69. Hagopian WA, Karlsen AE, Gottsater A, Landin-Olsson M. Grubin CE Sundqvist G et al. Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD-64) showed 64K autoantibody positivity at onset predicts diabetes type. J Clin Invest 1993; 91: 368-74.
70. Tuomi T, Groop LC, Zimmet PZ, Rowley MJ, Knowles W, Mackay IR. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes 1993; 42: 359-62.
71. Gottsäter A, Landin-Olsson M, Lernmark Å, Fernlund P, Sundkvist G, Hagopian WA. Glutamate decarboxylase antibody levels predict rate of beta-cell decline in adult onset diabetes. Diabetes Res Clin Prac 1995; 27: 133-40.
72. Richter W, Shi Y, Bækkeskov S. Autoreactive epitopes defined by diabetes-associated human monoclonal antibodies are localized in the middle and C-terminal domains of the smaller form of glutamate decarboxylase. Proc Natl Acad Sci USA 1993; 90: 2832-6.
73. Nepom GT. Immunogenetics and IDDM. Diabetes Reviews 1993; 1: 93-103.
74. Nepom GT. The major histocompatibility complex. Clin Immunother 1994; 2: 79-83.
75. Kwok WW, Nepom GT, Raymond FC. HLA-DQ polymorphisms are highly selective for peptide binding interactions. J Immunol 1995; 155: 2468-76.
76. Kwok WW, Domeier ME, Raymond FC, Byers P, Nepom GT. Allele-specific motifs characterize HLA-DQ interactions with a diabetes-associated peptide derived from glutamic acid decarboxylase. J Immunol 1996 (in press).
77. Kwok WW, Domeier ME, Johnson ML, Nepom GT, Koelle DM. HLA-DQB1 codon 57 is critical for peptide binding and recognition. J Exp Med 1996; 183: 1253-8.
78. Atkinson M, Bowman M, Campbell L, Darrow B, Kaufman DL, Maclaren NK. Cellular immunity to a determinant common to glutamate decarboxylase and Coxsackie virus in insulin dependent diabetes. J Clin Invest 1994; 94: 2125-9.
79. Harrison LC, Honeyman MC, Deaizpurua HJ, Schmidli RS, Colman PC, Tait BD, Cram DS. Inverse regulation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes. Lancet 1993; 341: 1365-9.
80. Richter W, Scißler J, Wolfahrt S, Scherbaum WA. Human monoclonal islet specific autoantibodies share features of islet cell and 64 kDa antibodies. Diabetologia 1993; 36: 785-90.
81. Richter W, Endl J, Eiermann TH, Brandt M, Kientsch-Engel R, Thivolet C, Jungfer H, Scherbaum WA. Human monoclonal islet cell antibodies from a patient with insulin-dependent diabetes mellitus reveal glutamate decarboxylase as the target antigen. Proc Natl Acad Sci USA 1992; 89: 846-7.
82. Richter W, Mertens T, Schoel B, Muir P, Ritzkowsky A, Scherbaum WA, Boehm B. Sequence homology of the disease-associated autoantigen glutamate decarboxylase with Cox-sackie B4-2C protein and heat shock protein 60 mediates no molecular mimicry of autoantibodies. J Exp Med 1994; 180: 721-6.
83. Haskins K, Portas M, Bergman B, Lafferty K, Bradley B. Pancreatic islet-specific T-cell clones from nonobese diabetic mice. Proc Natl Acad Sci USA 1989; 86: 8000-8004.
84. Petersen JS, Karlsen AE, Markholst H, Worsaae A, Dyrberg T, Michelsen B. Neonatal tolerization with glutamic acid decarboxylase but not with bovine serum albumin delays the onset of diabetes in NOD mice. Diabetes 1994; 43: 1478-84.
85. Falorni A, Nikosjkov A, Lauretti S, Grenback E, Hulting A-L, Casucci G et al. High diagnostic accuracy for idiopathic Addison's disease with a sensitive radiobinding assay for autoantibodies against recombinant human 21-hydroxylase. J Clin Endo Metab 1995; 80: 2752-5.